MaxCyte, Inc. (MXCT) Tops Q4 EPS by 2c
Tweet
Share
E-mail
Get Alerts MXCT Hot Sheet
Join SI Premium – FREE
MaxCyte, Inc. (NASDAQ: MXCT) reported Q4 EPS of ($0.10), $0.02 better than the analyst estimate of ($0.12). Revenue for the quarter came in at $8.7 million versus the consensus estimate of $7.76 million.
For earnings history and earnings-related data on MaxCyte, Inc. (MXCT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Barclays Upgrades 1&1 AG (1U1:GR) to Overweight
- Lonza Group (LONN:SW) (LZAGY) PT Raised to CHF720 at RBC Capital
- RBC Capital Starts Enact Holdings Inc (ACT) at Sector Perform
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
